Julie Rubinstein, President and COO at Adaptive Biotechnologies Corp (ADPT), sold 35,643 shares at $27.36 ($948K) on 2026-10-06, disclosed to the SEC on 2026-10-08.
Scheduled sale ($948k) by President and COO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.36 | 9,381 | $257K | 27.1% |
| 2 | $28.21 | 1,100 | $31K | 3.3% |
| 3 | $29.71 | 901 | $27K | 2.8% |
| 4 | $30.53 | 499 | $15K | 1.6% |
| 5 | $26.40 | 11,881 | $314K | 33.1% |
| 6 | $25.66 | 11,881 |
| $305K |
| 32.2% |
| Total | $26.60 avg | 35,643 | $948K | 100% |
| Filing → |
| ADPT | SELL | 2026-04-29 | $271K | — | Filing → |
| ADPT | SELL | 2026-04-24 | $798K | — | Filing → |
| ADPT | SELL | 2026-04-21 | $1.0M | — | Filing → |